Maria E. Marson

B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population.

Pharmacokinetics of two pharmaceutical presentations of benznidazole in adult Trypanosoma cruzi infected population.

Journal: Memorias do Instituto Oswaldo Cruz

Published: August 08, 2024

Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.

Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients.

Journal: Antimicrobial agents and chemotherapy

Published: September 12, 2020

Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease.

Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease.

Journal: PLoS neglected tropical diseases

Published: December 20, 2018

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.

Pharmacokinetic and pharmacodynamic responses in adult patients with Chagas disease treated with a new formulation of benznidazole.

Journal: Memorias do Instituto Oswaldo Cruz

Published: October 20, 2015

Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.

Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease.

Journal: Archives of disease in childhood

Published: September 12, 2014

Development of a LC-MS/MS methodology for the monitoring of the antichagasic drug benznidazole in human urine.

Development of a LC-MS/MS methodology for the monitoring of the antichagasic drug benznidazole in human urine.

Journal: Talanta

Published: March 16, 2014

Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole.

Identification of N-benzylacetamide as a major component of human plasmatic metabolic profiling of benznidazole.

Journal: European journal of drug metabolism and pharmacokinetics

Published: October 11, 2013

A simple and efficient HPLC method for benznidazole dosage in human breast milk.

A simple and efficient HPLC method for benznidazole dosage in human breast milk.

Journal: Therapeutic drug monitoring

Published: July 16, 2013

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.

Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults.

Journal: PLoS neglected tropical diseases

Published: January 14, 2013

Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma.

Development of an ionic liquid-based dispersive liquid-liquid microextraction method for the determination of nifurtimox and benznidazole in human plasma.

Journal: Talanta

Published: December 04, 2012

Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.

Development of UV/HPLC methods for quantitative analysis of benznidazole in human plasma and urine for application in pediatric clinical studies.

Journal: Journal of clinical laboratory analysis

Published: November 19, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026